PET/CT Pitfalls
- FDG follows glucose, and glucose feeds a lot more than tumors — muscle, brown fat, gut, infection, and healing tissue all light up too.
- The cardinal sin is calling something cancer just because it's bright. "Hot" means "metabolically busy," not "malignant."
- Many false positives are predictable: physiologic uptake has typical patterns and locations you can learn to recognize and dismiss.
- And the flip side — some real tumors barely glow. A cold lesion is not automatically benign.
- Always read the PET against the CT, the patient's prep, and the clinical story. The number alone lies.
FDG-PET is a wonderful, slightly gullible detective. You hand it a sugar molecule with a radioactive tag, and it dutifully reports every place in the body that's hungry for sugar. The problem is that "hungry for sugar" describes cancer, yes — but also a shivering patient, a clenched jaw, a busy colon, and a wound that's healing nicely. The scan can't tell ambition from appetite. That's our job.
So let's talk about the traps, because in PET/CT, being bright and being bad are two very different things.
Why everything glows: the FDG basics
FDG is fluorodeoxyglucose — glucose with a radioactive fluorine stuck on, and one chemical tweak that makes cells trap it instead of fully burning it. Cells that gobble glucose accumulate FDG and shine. Tumors do this because they're metabolically greedy. But so does any tissue working hard at the moment of the scan.
The brightness gets a number, the SUV (standardized uptake value). It's a useful shorthand, but treat it like a thermometer reading at a party: it tells you something's warm, not why. Inflammation can post a higher SUV than a sleepy tumor. Never let one number do your thinking.
The single most expensive mistake in PET reading is equating "hypermetabolic" with "malignant." Write that on the inside of your eyelids. Bright is a clue, not a verdict.
The usual suspects: physiologic false positives
Most false positives aren't exotic — they're the body doing normal body things, and they have signatures you can learn to wave off.
| Looks hot | What's actually happening | The tell |
|---|---|---|
| Symmetric neck/shoulder/paraspinal uptake | Brown fat burning sugar to make heat | Tracks fat on CT, symmetric, worse in cold/anxious patients |
| Tense neck and jaw muscles | Recent talking, chewing, or tension | Linear, follows muscle, both sides |
| Diffuse bowel uptake | Normal gut activity (or metformin) | Follows bowel loops, no CT mass |
| Bladder, kidneys, ureters | FDG is peed out — it's excreted in urine | Anatomic urinary tract, not a real lesion |
| Injection-site or vocal-cord uptake | Technique and talking artifacts | Location gives it away |
The big one is brown fat — that heat-generating tissue, mostly in the neck and upper chest, that flares up when a patient is cold or nervous. It can blaze on the scan and mimic lymph nodes. The fix is mostly prep: a warm, calm patient lights up far less. When you see symmetric uptake that hugs fat on the CT, think brown fat before you think lymphoma.
Infection and inflammation: the great impersonators
Here's the uncomfortable truth: FDG can't distinguish a tumor from a fight. White blood cells are sugar-hungry too, so abscesses, pneumonia, granulomas (think sarcoid or TB), fresh surgical beds, and recently irradiated tissue can all light up impressively.
This is why timing matters. Scan too soon after surgery, biopsy, or radiation, and you'll see hot inflammation where the knife or beam was — easily misread as residual or recurrent tumor.
Give the body time. Inflammatory uptake after surgery or radiation fades with weeks, so scans are usually deferred a sensible interval after treatment to let the "healing glow" settle. Always check what was done, and when.
The cold trap: when cancer doesn't shine
Now flip the whole thing over. The mirror-image error is assuming that if it's not bright, it must be benign. Some malignancies are genuinely faint on FDG.
Tumors that are mucinous, very well-differentiated, or simply small and slow can sip glucose rather than gulp it — so they glow weakly or not at all. Classic low-FDG offenders include some low-grade and mucinous tumors, and certain neuroendocrine and prostate cancers that prefer entirely different tracers. A lesion you can see on CT but that stays dark on PET deserves respect, not dismissal.
"It's not hot, so it's nothing" is just as dangerous as "it's hot, so it's cancer." FDG-avidity is a property of the tumor's metabolism, not a measure of how serious it is. Some aggressive cancers are simply quiet on FDG — which is exactly why other tracers like PSMA and DOTATATE exist for them. (More in theranostics.)
Technical gremlins: when the picture itself lies
Even a perfectly real finding can be plotted in the wrong place. PET and CT are acquired separately and then stacked, and the patient breathes in between. So a lung nodule near the diaphragm can get smeared or shifted relative to its CT outline — misregistration.
Dense stuff causes its own mischief. Metal implants, contrast pooling, and big calcifications can distort the attenuation correction — the math that compensates for how much signal gets absorbed on the way out — and conjure artifactual hot or cold spots. The habit that saves you: when something looks off, pull up the non-attenuation-corrected images and the plain CT and see if the finding holds up in all three.
How to not get fooled
The throughline is the same every time: never read the PET in isolation. Lean on the physiology of nuclear medicine, the CT anatomy underneath, the patient's prep and glucose, and the clinical question.
Before you commit to a hot spot, run the quick gut-check: Is this a known physiologic site? Is it symmetric? Recent surgery, infection, or radiation? Does it land on a real CT abnormality, or is it floating in fat or urine? Ask those five questions and most false positives quietly disqualify themselves — leaving the findings that actually deserve your worry.
If you remember one thing: PET tells you where the body is busy. You still have to decide why.